$0.30
13.14% yesterday
Nasdaq, Jul 02, 10:03 pm CET
ISIN
US91381U1016
Symbol
UBX
Sector
Industry

Unity Biotechnology, Inc. Stock price

$0.30
-0.42 58.40% 1M
-0.84 73.86% 6M
-0.68 69.48% YTD
-1.01 77.25% 1Y
-5.96 95.24% 3Y
-89.30 99.67% 5Y
-166.20 99.82% 10Y
-166.20 99.82% 20Y
Nasdaq, Closing price Wed, Jul 02 2025
-0.05 13.14%
ISIN
US91381U1016
Symbol
UBX
Sector
Industry

Key metrics

Basic
Market capitalization
$5.9m
Enterprise Value
$-11.0m
Net debt
positive
Cash
$16.9m
Shares outstanding
17.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.50
P/B
negative
Financial Health
Equity Ratio
17.24%
Return on Equity
-400.22%
ROCE
-143.15%
ROIC
-
Debt/Equity
0.00
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-29.7m | $-40.4m
EBIT
$-30.5m
Net Income
$-27.5m | $-21.4m
Free Cash Flow
$-22.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
26.00% | -46.20%
EBIT
25.96%
Net Income
26.73% | 17.85%
Free Cash Flow
28.81%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.62
FCF per Share
$-1.28
Short interest
3.39%
Employees
16.00
Rev per Employee
$0.00
Show more

Is Unity Biotechnology, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,965 stocks worldwide.

Unity Biotechnology, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Unity Biotechnology, Inc. forecast:

5x Buy
63%
3x Hold
38%

Analyst Opinions

8 Analysts have issued a Unity Biotechnology, Inc. forecast:

Buy
63%
Hold
38%

Financial data from Unity Biotechnology, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 16 16
12% 12%
-
- Research and Development Expense 12 12
32% 32%
-
-30 -30
26% 26%
-
- Depreciation and Amortization 0.82 0.82
24% 24%
-
EBIT (Operating Income) EBIT -30 -30
26% 26%
-
Net Profit -28 -28
27% 27%
-

In millions USD.

Don't miss a Thing! We will send you all news about Unity Biotechnology, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Unity Biotechnology, Inc. Stock News

Neutral
GlobeNewsWire
2 months ago
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the Company will present 36-week data from the ASPIRE Phase 2B study at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting being held on M...
Neutral
GlobeNewsWire
2 months ago
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
3 months ago
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidence interval), but did not meet statistical non-inferiority on the average of weeks 20 and 24, the primary analysis endpoint (met at 88% confidence interval) UBX1325-treated patients had a +5.2 lette...
More Unity Biotechnology, Inc. News

Company Profile

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.

Head office United States
CEO Anirvan Ghosh
Employees 16
Founded 2009
Website unitybiotechnology.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today